Novo Nordisk Aktie
64,08
EUR
-1,30
EUR
-1,99
%
60,86
CHF
-0,68
CHF
-1,11
%
Werbung
Novo Nordisk Aktie Analyse
05.02.20 | Novo Nordisk overweight | Barclays Capital | |
05.02.20 | Novo Nordisk Outperform | Bernstein Research | |
05.02.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
31.01.20 | Novo Nordisk overweight | Barclays Capital | |
29.01.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
27.01.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
20.01.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
17.01.20 | Novo Nordisk overweight | Barclays Capital | |
Werbung
|
|||
17.01.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
16.01.20 | Novo Nordisk overweight | Barclays Capital | |
16.01.20 | Novo Nordisk Outperform | Credit Suisse Group | |
06.01.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
06.01.20 | Novo Nordisk kaufen | Bernstein Research | |
21.11.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
21.11.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
18.11.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
18.11.19 | Novo Nordisk overweight | Barclays Capital | |
06.11.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
04.11.19 | Novo Nordisk Outperform | Credit Suisse Group | |
04.11.19 | Novo Nordisk Outperform | Bernstein Research | |
04.11.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
01.11.19 | Novo Nordisk buy | UBS AG | |
01.11.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
28.10.19 | Novo Nordisk Outperform | Credit Suisse Group | |
21.10.19 | Novo Nordisk buy | UBS AG | |
09.10.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
04.10.19 | Novo Nordisk Outperform | Credit Suisse Group | |
23.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
20.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
19.09.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
18.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
12.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
09.09.19 | Novo Nordisk Outperform | Bernstein Research | |
05.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
02.09.19 | Novo Nordisk buy | UBS AG | |
28.08.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
20.08.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
12.08.19 | Novo Nordisk Outperform | Credit Suisse Group | |
09.08.19 | Novo Nordisk buy | UBS AG | |
09.08.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
09.08.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
02.08.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
31.07.19 | Novo Nordisk buy | UBS AG | |
08.07.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
04.07.19 | Novo Nordisk Conviction Buy | Goldman Sachs Group Inc. | |
18.06.19 | Novo Nordisk buy | UBS AG | |
17.06.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
14.06.19 | Novo Nordisk buy | Deutsche Bank AG | |
12.06.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
11.06.19 | Novo Nordisk Outperform | Credit Suisse Group |
Werbung
Werbung